SABS

SAB Biotherapeutics, Inc.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1833214Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

3 managers · Q2 2026 13F

13F bookWeight

Vivo Capital

Vivo CapitalPosition history →

2.6%

(36.1%)

$28.5M

$1.10B13F book · 2026-06-30

RA Capital Management

RA Capital ManagementPosition history →

0.15%

—

$17.2M

$11.51B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.04%

+88.1%

$25.0M

$71.32B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.